-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades BeOne Medicines to Buy, Raises Price Target to $380

Benzinga·07/13/2026 10:49:17
語音播報
Jefferies analyst Faisal Khurshid upgrades BeOne Medicines (NASDAQ:ONC) from Hold to Buy and raises the price target from $333 to $380.